Comera Life Sciences Holdings, Inc. Common Stock
CMRA
CMRA was delisted on the 16th of November, 2023.
16 hedge funds and large institutions have $941K invested in Comera Life Sciences Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
60% more funds holding
Funds holding: 10 → 16 (+6)
33% more capital invested
Capital invested by funds: $710K → $941K (+$231K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSAG
Lake Street Advisors Group
Portsmouth,
New Hampshire
|
+$518K |
| 2 |
AI
Arena Investors
Purchase,
New York
|
+$203K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$115K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$114K |
| 5 |
VF
Virtu Financial
New York
|
+$36.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$115K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$85.1K |
| 3 |
JF
Jump Financial
Chicago,
Illinois
|
-$58K |
| 4 |
Squarepoint
New York
|
-$40K |
| 5 |
BCM
Bluefin Capital Management
New York
|
-$19K |
CMRA Hedge Fund Activity: Q3 2022 in Review
16 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Common Stock (CMRA) for Q3 2022, worth a combined $941K — up 33% from $710K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CMRA positions and 3 closed out — a net gain of 6 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Lake Street Advisors Group, adding an estimated $518K. The largest seller was Jane Street, exiting entirely with an estimated $115K sold.
- 16 institutional investors held Comera Life Sciences Holdings, Inc. Common Stock (CMRA) as of Q3 2022, up from 10 in Q2 2022.
- Funds reported $941K of Comera Life Sciences Holdings, Inc. Common Stock stock for Q3 2022, up 33% quarter-over-quarter.
- 9 funds opened new Comera Life Sciences Holdings, Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of +6 holders.
- The largest Comera Life Sciences Holdings, Inc. Common Stock buyer in Q3 2022 was Lake Street Advisors Group, an estimated $518K added.
- The largest Comera Life Sciences Holdings, Inc. Common Stock seller in Q3 2022 was Jane Street, an estimated $115K sold.
Based on aggregated 13F filings for Q3 2022.